Topics

U.S. FDA approves RedHill's H. pylori infection treatment

01:23 EST 4 Nov 2019 | Reuters

The U.S. Food and Drug Administration has approved RedHill Biopharma Ltd's drug to treat infections caused by bacteria known as Helicobacter pylori, the Israel-based company said on Monday.

Original Article: U.S. FDA approves RedHill's H. pylori infection treatment

NEXT ARTICLE

More From BioPortfolio on "U.S. FDA approves RedHill's H. pylori infection treatment"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...